PRINCETON, N.J., September 24, 2025--(BUSINESS WIRE)--Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Iron therapy is a medical treatment used to correct severe iron deficiency when it cannot be managed through diet or regular oral supplements. When the body lacks sufficient iron, it leads to low ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved the first-ever IV iron replacement therapy to improve exercise capacity in adults with ...

Panelists discuss how chronic kidney disease leads to iron deficiency anemia through a complex interplay of impaired iron absorption, increased hepcidin production driven by inflammatory cytokines, ...

Viatris Inc. (NASDAQ: VTRS) announced that the U.S. Food and Drug Administration has approved Iron Sucrose Injection, USP, marking the first generic version of Venofer Injection in the United States.

Please provide your email address to receive an email when new articles are posted on . The FDA approved the first and only IV iron replacement therapy indicated for people with heart failure and iron ...

The FDA approved a label change for ferric carboxymaltose injection (Injectafer) that adds a boxed warning for the risk of symptomatic hypophosphatemia. The agency recommends monitoring of phosphate ...

Approval Granted with Competitive Generic Therapy Eligibility for 100mg/5mL and 200mg/10mL Strengths; Provides Eligibility for 180 Days of Exclusivity Viatris' robust complex injectable pipeline ...